AI-Base ECG Software
AllOfRemedies AI-Based ECG software supports diagnostic aid that analyzes ECGs and assesses AI disease risk scores for : Left Ventricular Systolic Dysfunction and Myocardial Infarction.
Clinical Overview & Details
This is a software diagnostic aid that analyzes
ECGs and assesses AI disease risk scores.
Left Ventricular Systolic Dysfunction
The software as a medical device analyzes 12-lead ECG data using artificial intelligence to indicate the likelihood of left ventricular systolic dysfunction with scores and risk assessment.
Pivotal Clinical Study
Pivotal clinical studies with over 2000 patientsadults with suspected acute myocardial infarction (prevalence 15%) have proven reliable outcomes.
Primary outcome : AUROC 0.917 (95% confidence interval 0.897-0.936)
Secondary outcome : Negative predictive value of 100% for the low-risk group (cutoff: less than 3.0) Positive predictive value of 56.4% for the high-risk group (cutoff: 48.5 or higher)
Key Highlights & Benefits
Rapid Automated Processing
Accelerates radiological reading speed while minimizing diagnostic errors.
Subtle Anomaly Detection
Identifies early-stage findings with deep learning neural networks.
Seamless PACS Integration
Integrates directly into hospital workflows without workflow disruption.
Quantitative Metrics
Generates automated volumetric and progression tracking metrics.
Request Live Demonstration
Experience AI-Base ECG Software with your clinical team. Schedule a custom evaluation.